SCHEMBL25534974

SCHEMBL25534974

c1ccc(C2(c3ccccc3)c3ccccc3-c3cc(-c4ccc(-c5cc(-c6ccc7ccccc7c6)nc(-c6cccc7ccccc67)n5)c5ccccc45)ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.40
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CYP1A2 P05177 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MCL1 Q07820 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
CTRC Q99895 1/20 0.32
MAPT P10636 3/20 0.32
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
OPRK1 P41145 1/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25535187 1.00 PIM1 (0.40) PIM1CYP1A1CYP1B1CYP1A2MEN1
SCHEMBL25535111 0.97 PIM1 (0.39) PIM1CYP1A1CYP1B1CYP1A2MEN1
SCHEMBL25534641 0.96 PIM1 (0.42) PIM1CYP1A1CYP1B1CYP1A2MEN1
SCHEMBL25534911 0.96 PIM1 (0.42) PIM1CYP1A1CYP1B1CYP1A2MEN1
SCHEMBL25534984 0.94 MEN1 (0.37) CYP1A2MEN1KMT2AMCL1ACMSD
SCHEMBL25534787 0.93 PIM1 (0.40) PIM1CYP1A1CYP1B1CYP1A2MEN1
SCHEMBL25535179 0.93 CHRNA1 (0.35) CYP1A2MEN1KMT2AMCL1ACMSD
SCHEMBL25534973 0.93 CHRNA1 (0.35) CYP1A2MEN1KMT2AMCL1ACMSD
SCHEMBL25535184 0.93 CYP1A1 (0.44) PIM1CYP1A1CYP1B1CYP1A2MEN1
SCHEMBL25535193 0.92 CYP1A1 (0.43) PIM1CYP1A1CYP1B1CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM PIM1 1763/4885CYP1A1 888/4885CYP1B1 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.